Parasitology Research

, Volume 92, Issue 4, pp 289–298 | Cite as

Characterisation and differentiation of pathogenic and non-pathogenic Acanthamoeba strains by their protein and antigen profiles

  • J. Walochnik
  • K. Sommer
  • A. Obwaller
  • E.-M. Haller-Schober
  • H. Aspöck
Original Paper

Abstract

Free-living amoebae of the genus Acanthamoeba are the causative agents of Acanthamoeba keratitis (AK) and granulomatous amoebic encephalitis. Acanthamoebae occur ubiquitously in the environment and are thus a constant cause of antigenic stimulation. In a previous study we have shown that compared to control sera, AK patients exhibit markedly lower immunoreactivities to whole cell antigen of Acanthamoeba spp. As the pathogenicity of acanthamoebae primarily relies on the excretion of proteins, it was the aim of the present study to investigate the immunoreactivity of metabolic antigen from different Acanthamoeba strains of varying pathogenicity. Three Acanthamoeba strains, one highly pathogenic, one non-pathogenic but thermophilic and one non-thermophilic non-pathogenic, were used for antigen extraction. The antigen was harvested before and after contact with human cells and all strains were tested with AK sera and with sera from healthy individuals. It was shown that the somatic protein profiles of the Acanthamoeba strains correlated to the morphological groups, and that within morphological group II—the group associated with AK—the profiles of the metabolic antigens correlated to strain pathogenicity. Moreover, it was shown that the control sera showed markedly higher immunoreactivities than the sera of the AK patients and that this immunoreactivity was generally higher to the non-pathogenic strains than to the pathogenic strain. Altogether our results once again raise the question of whether there is an immunological predisposition in AK. To our knowledge this is the first study on the immunoreactivity of metabolic antigen of acanthamoebae.

Notes

Acknowledgements

The authors wish to thank Dr R. Michel from the Department of Parasitology of the Central Institute of the Armed Forces Medical Services, Koblenz, Germany for providing the Acanthamoeba strains Am23, 302–2, 312–2, 45/1 and 72/2. All work was done according to the Austrian Gene Technology Law and following the NIH guidelines. Moreover, the safety regulations of the European Community for working with biologically and chemically hazardous material were strictly adhered to.

References

  1. Alizadeh H, He YG, McCulley JP, Ma D, Stewart GL, Via M, Haehling E, Niederkorn JY (1995) Successful immunization against Acanthamoeba in a pig model. Cornea 14:180–186PubMedGoogle Scholar
  2. Blackman HJ, Rao NA, Lemp MA, Visvesvara GS (1984) Acanthamoeba keratitis successfully treated with penetrating keratoplasty: suggested immunogenic mechanisms of action. Cornea 3:125–130PubMedGoogle Scholar
  3. Cerva L (1989) Acanthamoeba culbertsoni and Naegleria fowleri: occurrence of antibodies in man. J Hyg Epidemiol Microbiol Immunol 33:99–103PubMedGoogle Scholar
  4. Cerva L, Serbus C, Skocil V (1973) Isolation of limax amoebas from the nasal mucosa of man. Folia Parasitol 20:97–103PubMedGoogle Scholar
  5. Chappell CL, Wright JA, Coletta M, Newsome AL (2001) Standardized method of measuring Acanthamoeba antibodies in sera from healthy human subjects. Clin Diagn Lab Immunol 8:724–730CrossRefPubMedGoogle Scholar
  6. Cohen E, Fulton J, Hoffman C, Rapuano C, Laibson P (1996) Trends in contact lens-associated corneal ulcers. Cornea 15:566–570PubMedGoogle Scholar
  7. Cursons RT, Brown TJ, Keys EA, Moriarty KM, Till D (1980) Immunity to pathogenic free-living amoebae: role of humoral antibody. Infect Immun 29:401–407PubMedGoogle Scholar
  8. De Jonckheere JF (1991) Ecology of Acanthamoeba. Rev Infect Dis 13:S385-S387PubMedGoogle Scholar
  9. De Jonckheere JF, Michel R (1988) Species identification and virulence of Acanthamoeba strains from human nasal mucosa. Parasitol Res 74:314–316PubMedGoogle Scholar
  10. Donzis PB, Mondino BJ, Weissman BA, Bruckner DA (1987) Microbial contamination of contact lens care systems. Am J Ophthalmol 104:325–333PubMedGoogle Scholar
  11. Ferrante A (1991) Free-living amoebae: pathogenicity and immunity. Parasite Immunol 13:31–47PubMedGoogle Scholar
  12. Gast RJ, Ledee DR, Fuerst PA, Byers TJ (1996) Subgenus systematics of Acanthamoeba: four nuclear 18S rDNA sequence types. J Eukaryot Microbiol 43:498–504PubMedGoogle Scholar
  13. He YG, Niederkorn JY, McCulley JP, Stewart GL, Meyer DR, Silvany R, Dougherty J (1990) In vivo and in vitro collagenolytic activity of Acanthamoeba castellanii. Invest Ophthalmol Vision Sci 31:2235–2240Google Scholar
  14. Khan NA, Jarroll EL, Paget TA (2002) Molecular and physiological differentiation between pathogenic and nonpathogenic Acanthamoeba. Curr Microbiol 45:197–202CrossRefPubMedGoogle Scholar
  15. Klink F van, Leher H, Jager MJ, Alizadeh H, Taylor W, Niederkorn JY (1997) Systemic immune response to Acanthamoeba keratitis in the Chinese hamster. Ocul Immunol Inflamm 5:235–244PubMedGoogle Scholar
  16. Kong H-H, Kim T-H, Chung d -I (2000) Purification and characterization of a secretory serine proteinase of Acanthamoeba healyi isolated from GAE. J Parasitol 86:12–17PubMedGoogle Scholar
  17. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685PubMedGoogle Scholar
  18. Lam DS, Houang E, Fan DS, Lyon D, Seal D, Wong E (2002) Incidence and risk factors for microbial keratitis in Hong Kong: comparison with Europe and North America. Eye 16:608–618CrossRefPubMedGoogle Scholar
  19. Leher H, Alizadeh H, Taylor WM, Shea AS, Silvany RS, Van Klink F, Jager MJ, Niederkorn JY (1998a) Role of mucosal IgA in the resistance to Acanthamoeba keratitis. Invest Ophthalmol Vision Sci 39:2666–2673Google Scholar
  20. Leher H, Kinoshita K, Alizadeh H, Zaragoza FL, He Y, Niederkorn J (1998b) Impact of oral immunization with Acanthamoeba antigens on parasite adhesion and corneal infection. Invest Ophthalmol Vision Sci 39:2237–2243Google Scholar
  21. Leher H, Silvany R, Alizadeh H, Huang J, Niederkorn JY (1998c) Mannose induces the release of cytopathic factors from Acanthamoeba castellanii. Infect Immun 66:5–10PubMedGoogle Scholar
  22. Leher H, Zaragoza F, Taherzadeh S, Alizadeh H, Niederkorn JY (1999) Monoclonal IgA antibodies protect against Acanthamoeba keratitis. Exp Eye Res 69:75–84CrossRefPubMedGoogle Scholar
  23. Marciano-Cabral F, Cabral G (2003) Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev 16:273–307CrossRefPubMedGoogle Scholar
  24. Marciano-Cabral F, Toney DM (1998) The interaction of Acanthamoeba spp. with activated macrophages and with macrophage cell lines. J Euk Microbiol 45:452–458PubMedGoogle Scholar
  25. Martinez AJ, Visvesvara GS (1997) Free-living, amphizoic and opportunistic amebas. Brain Pathol 7:583–598PubMedGoogle Scholar
  26. Mathers W, Stevens G Jr, Rodrigues M, Chan CC, Gold J, Visvesvara GS, Lemp MA, Zimmerman LE (1987) Immunopathology and electron microscopy of Acanthamoeba keratitis. Am J Ophthalmol 103:626–635PubMedGoogle Scholar
  27. Mattana A, Tozzi MG, Costa M, Delogu G, Fiori PL, Cappuccinelli P (2001) By releasing ADP, Acanthamoeba castellanii causes an increase in the cytosolic free calcium concentration and apoptosis in wish cells. Infect Immun 69:4134–4140CrossRefPubMedGoogle Scholar
  28. Mattana A, Cappai V, Alberti L, Serra C, Fiori PL, Cappuccinelli P (2002) ADP and other metabolites released from Acanthamoeba castellanii lead to human monocytic cell death through apoptosis and stimulate the secretion of proinflammatory cytokines. Infect Immun 70:4424–4432CrossRefPubMedGoogle Scholar
  29. McClellan K, Howard K, Mayhew E, Niederkorn J, Alizadeh H (2002) Adaptive immune responses to Acanthamoeba cysts. Exp Eye Res 75:285–293CrossRefPubMedGoogle Scholar
  30. Mergeryan H (1991) The prevalence of Acanthamoeba in the human environment. Rev Inf Dis 13:S390-S391Google Scholar
  31. Michel R, Röhl R, Schneider H (1982) Isolation of free-living amoebae from nasal mucosa of healthy individuals. Zbl Bakt Hyg 176:155–159Google Scholar
  32. Moore MB, McCulley JP, Luckenbach M, Gelender H, Newton C, McDonald MB, Visvesvara GS (1985) Acanthamoeba keratitis associated with soft contact lenses. Am J Ophthalmol 100:396–403PubMedGoogle Scholar
  33. Moore MB, Ubelaker JE, Martin JH, Silvany R, Dougherty JM, Meyer DR, McCulley JP (1991) In vitro penetration of human corneal epithelium by Acanthamoeba castellanii: a scanning and transmission electron microscopic study. Cornea 10:291–298PubMedGoogle Scholar
  34. Na BK, Cho JH, Song CY, Kim TS (2002) Degradation of immunoglobulins, protease inhibitors and interleukin-1 by a secretory proteinase of Acanthamoeba castellanii. Korean J Parasitol 40:93–99PubMedGoogle Scholar
  35. Nagington F, Watson PG, Playfair TJ, McGill J, Hones BR, Steele ADM (1974) Amoebic infection of the eye. Lancet 2:1537–1540CrossRefPubMedGoogle Scholar
  36. Niederkorn JY (2002a) Immune privilege in the anterior chamber of the eye. Crit Rev Immunol 22:13–46PubMedGoogle Scholar
  37. Niederkorn JY (2002b) The role of the innate and adaptive immune responses in Acanthamoeba keratitis. Arch Immunol Ther Exp (Warsz) 50:53–59Google Scholar
  38. Niederkorn JY, Alizadeh H, Leher H, McCulley JP (1999) The pathogenesis of Acanthamoeba keratitis. Microbes Infect 1:437–443CrossRefPubMedGoogle Scholar
  39. Pearlman E (1997) Immunopathology of onchocerciasis: a role for eosinophils in onchocercal dermatitis and keratitis. Chem Immunol 66:26–40PubMedGoogle Scholar
  40. Powell EL, Newsome AL, Allen, SD, Knudson GB (1994) Identification of antigens of pathogenic free-living amoebae by protein immunoblotting with rabbit immune and human sera. Clin Diagn Lab Immunol 1:493–499PubMedGoogle Scholar
  41. Pussard M, Pons R (1977) Morphologie de la paroi kystique et taxonomie du genre Acanthamoeba (Protozoa, Amoebida). Protistologica 8:557–598Google Scholar
  42. Que X, Reed SL (2000) Cysteine proteinases and the pathogenesis of amebiasis. Clin Microbiol Rev 13:196–206PubMedGoogle Scholar
  43. Radford CF, Minassian DC, Dart JK (2002) Acanthamoeba keratitis in England and Wales: incidence, outcome, and risk factors. Br J Ophthalmol 86:536–542CrossRefPubMedGoogle Scholar
  44. Schaumberg DA, Snow KK, Dana MR (1998) The epidemic of Acanthamoeba keratitis: where do we stand? Cornea 17:3–10PubMedGoogle Scholar
  45. Shandil RK, Vinayak VK (1990) Immunoreactivity of Entamoeba histolytica antigens with sera from amoebic patients. Med Microbiol Immunol (Berl) 179:263–269Google Scholar
  46. Stewart GL, Kim I, Shupe K, Alizadeh H, Silvany R, McCulley JP, Niederkorn JY (1992) Chemotactic response of macrophages to Acanthamoeba castellanii antigen and antibody-dependent macrophage-mediated killing of the parasite. J Parasitol 78:849–855PubMedGoogle Scholar
  47. Stewart GL, Shupe K, Kim I, Silvany H, Alizadeh H, McCulley JP, Niederkorn JY (1994) Antibody-dependent neutrophil-mediated killing of Acanthamoeba c astellanii. Int J Parasitol 24:739–742CrossRefPubMedGoogle Scholar
  48. Stothard DR, Schroeder-Diedrich JM, Awwad MH, Gast RJ, Ledee DR, Rodriguez-Zaragoza S, Dean CL, Fuerst PA, Byers TJ (1998) The evolutionary history of the genus Acanthamoeba and the identification of eight new 18S rRNA gene sequence types. J Eukaryot Microbiol 45:45–54PubMedGoogle Scholar
  49. Streilein JW, Dana MR, Ksander BR (1997) Immunity causing blindness: five different paths to herpes stromal keratitis. Immunol Today 18:443–449CrossRefPubMedGoogle Scholar
  50. Visvesvara GS, Balamuth W (1975) Comparative studies on related free-living and pathogenic amebae with special reference to Acanthamoeba. J Protozool 22:245–256PubMedGoogle Scholar
  51. Walochnik J, Haller-Schober EM, Kölli H, Picher O, Obwaller A, Aspöck H (2000a) Discrimination between clinically relevant and nonrelevant Acanthamoeba strains isolated from contact lens wearing keratitis patients in Austria. J Clin Microbiol 38:3932–3936PubMedGoogle Scholar
  52. Walochnik J, Obwaller A, Aspöck H (2000b) Correlations between morphological, molecular biological, and physiological characters in clinical and non-clinical isolates of Acanthamoeba spp. Appl Environ Microbiol 66:4408–4413CrossRefPubMedGoogle Scholar
  53. Walochnik J, Obwaller A, Aspöck H (2001a) Immunological inter-strain crossreactivity correlated to 18S rDNA sequence types in Acanthamoeba spp. Int J Parasitol 31:163–167CrossRefPubMedGoogle Scholar
  54. Walochnik J, Obwaller A, Aspöck H (2001b) Anti-Acanthamoeba IgG, IgM, and IgA immunoreactivity of Acanthamoeba keratitis patients and asymptomatic individuals. Parasitol Res 87:651–656CrossRefPubMedGoogle Scholar
  55. Walochnik J, Haller-Schober EM, Kölli H, Picher O, Obwaller A, Aspöck H (2002) Acanthamoeba -Keratitis in Österreich: Klinische, mikrobiologische und epidemiologische Befunde. Mitt Österr Ges Tropenmed Parasitol 23:17–26Google Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • J. Walochnik
    • 1
  • K. Sommer
    • 1
  • A. Obwaller
    • 1
  • E.-M. Haller-Schober
    • 2
  • H. Aspöck
    • 1
  1. 1.Department of Medical Parasitology, Clinical Institute of Hygiene and Medical MicrobiologyUniversity of ViennaViennaAustria
  2. 2.Department of OphthalmologyKarl-Franzens-UniversityA-GrazAustria

Personalised recommendations